Are your kidneys Ok? Detect early to protect kidney health

被引:0
|
作者
Vassalotti, protect kidney Joseph A. [1 ,2 ]
Francis, Anna [3 ]
dos Santos Jr, Augusto Cesar Soares [4 ]
Correa-Rotter, Ricardo [5 ]
Abdellatif, Dina [6 ]
Hsiao, Li-Li [7 ]
Roumeliotis, Stefanos [8 ]
Haris, Agnes [9 ]
Kumaraswami, Latha A. [10 ]
Lui, Siu-Fai [11 ]
Balducci, Alessandro [12 ]
机构
[1] Mt Sinai Hosp, Med Serv, New York, NY USA
[2] Natl Kidney Fdn Inc, New York, NY USA
[3] Queensland Childrens Hosp, Dept Nephrol, 501 Stanley St, South Brisbane, Qld 4101, Australia
[4] Univ Fed Minas Gerais UFMG, Fac Ciencias Med Minas Gerais, Dept Psychol, Ebserh, MG, Brazil
[5] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, Mexico
[6] Cairo Univ, Dept Nephrol, Cairo, Egypt
[7] Harvard Med Sch, Brigham & Womens Hosp, Renal Div Dept Med, Boston, MA 02115 USA
[8] Aristotle Univ Thessaloniki, Amer Hellen Educ Progress Assoc AHEPA, Dept Nephrol 2, Univ Hosp Med Sch, 1 St Kyriakidi Str, Thessaloniki 54636, Greece
[9] Peterfy Hosp, Neurol Dept, Budapest, Hungary
[10] Tamilnad Kidney Res Tanker Fdn, Chennai, Tamil Nadu, India
[11] Chinese Univ Hong Kong, Jockey Club Sch Publ Hlth & Primary Care, Div Hlth Syst Policy & Management, Shatin, Hong Kong, Peoples R China
[12] Italian Kidney Fdn, Rome, Italy
关键词
DISEASE; CARE; CKD; PATIENT; ACCESS;
D O I
10.1016/j.kint.2024.12.006
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Early identification of kidney disease can protect kidney health, prevent kidney disease progression and related complications, reduce cardiovascular disease risk, and decrease mortality. We must ask "Are your kidneys ok?" using serum creatinine to estimate kidney function and urine albumin to assess for kidney and endothelial damage. Evaluation for causes and risk factors for chronic kidney disease (CKD) includes testing for diabetes and measurement of blood pressure and body mass index. This World Kidney Day we assert that case-finding in high-risk populations, or even population level screening, can decrease the burden of kidney disease globally. Early-stage CKD is asymptomatic and simple to test for, and recent paradigm shifting CKD treatments such as sodium glucose co-transporter-2 inhibitors dramatically improve outcomes and favor the cost-benefit analysis for screening or case-finding programs. Despite this, numerous barriers exist, including resource allocation, health care funding, health care infrastructure, and health care professional and population awareness of kidney disease. Coordinated efforts by major kidney nongovernmental organizations to prioritize the kidney health agenda for governments and aligning early detection efforts with other current programs will maximize efficiencies.
引用
收藏
页码:370 / 377
页数:8
相关论文
共 50 条